RSV & COPD: New Vaccines & Boosters Explained

by drbyos

The Ministry of Health and Social Services has updated the common calendar of vaccinations and immunizations throughout life, which incorporates, as the main novelty, vaccination against the respiratory syncytial virus (RSV) in adults with high-risk conditions and in institutionalized seniors.

The Official Gazette of Extremadura (DOE) has published a resolution that adapts the regional recommendations to the agreements adopted by the Public Health Commission of the Interterritorial Council of the National Health System in December 2025. Among the most notable developments is the introduction of the RSV vaccine in especially vulnerable adults, such as people with hematological cancer undergoing treatment, patients on dialysis, solid organ transplants, people with severe immunodeficiencies or advanced HIV infection, as well as in over 60 years of age residing in social health centers.

Likewise, the Board has incorporated the vaccine against diphtheria, tetanus and pertussis (dTpa) for adults with chronic obstructive pulmonary disease (COPD) who do not have a previous dose in adulthood, with the aim of reducing the risk of respiratory complications.

The resolution also maintains the vaccination schedule against herpes zoster, which will continue to progressively immunize the groups of people who turn 65 and 80 years of age each year. In 2026, vaccination will target people born in 1946 and 1961, as well as those from earlier cohorts who have not yet received the corresponding dose.

Along with these measures, the document updates the specific calendars for minors, adolescents and adults with risk conditions, reinforcing protection against diseases such as influenza, COVID-19, pneumococcus, hepatitis or human papillomavirus.

The new calendars must be applied in all public and private health centers in the autonomous community and come into force from their publication in the DOE.

Related Posts

Leave a Comment